Muscle Loss and Daily Life in People with Heart Failure
Studies how income, activity, diet and lifestyle relate to muscle loss in heart failure.
Plain-language title generated from the registry record
Registry title: Mechanism of Sarcopenia in Heart Failure
Key facts
- Where
- Aarhus N, DenmarkSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT05063955, who can take part
Where in Denmark
- Aarhus University HospitalAarhus N, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Aarhus University Hospital
- Trial code
- NCT05063955
- Record updated
- 26 December 2023
- Original description
The aim of the study is to provide information on the interaction between socioeconomic factors, daily physical activity, nutrition and lifestyle on loss of muscle mass and muscle function in patients with heart failure.Read full original descriptionShow less
Socioeconomic Factors and Mechanisms of Sarcopenia and Muscle Strength in Chronic Heart Failure Patients
The aim of the study is to provide information on the interaction between socioeconomic factors, daily physical activity, nutrition and lifestyle on loss of muscle mass and muscle function in patients with heart failure.
Inclusion: Ability to provide valid informed consent; Heart failure with preserved, mid-range or reduced ejection fraction (NYHA I-IV) according to European Society of Cardiology guidelines.
Exclusion: Severe lung disease with a forced expiratory volume 1 < 40% of predicted. Treatment with anticoagulants (warfarin, apixaban, edoxaban, dabigatran and rivaroxaban) is an exclusion criterion for muscle biopsy. Patients with anticoagulant treatment will be invited to participate in the study without muscle biopsy; Cancer requiring treatment (e.g. prostate cancer on watchful waiting does not exclude patients); Severe musculoskeletal or neurological disability; Other comorbidities that prevent the patient from participating in the study examinations as judged by the investigator.